Canlyniadau Chwilio - Witjes, Han

Corifollitropin alfa or rFSH treatment flexibility options for controlled ovarian stimulation: a post hoc analysis of the Engage trial gan Leader, Arthur, Devroey, Paul, Witjes, Han, Gordon, Keith

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Meta‐Analyses of Clinical Efficacy of Risankizumab and Adalimumab in Chronic Plaque Psoriasis: Supporting Evidence of Risankizumab Superiority gan Witjes, Han, Khatri, Amit, Diderichsen, Paul M., Mandema, Jaap, Othman, Ahmed A.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Clinical impact of LH rises prior to and during ganirelix treatment started on day 5 or on day 6 of ovarian stimulation gan Frattarelli, John L, Hillensjö, Torbjörn, Broekmans, Frank J, Witjes, Han, Elbers, Jolanda, Gordon, Keith, Mannaerts, Bernadette

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Population pharmacokinetics and exposure‐response of osimertinib in patients with non‐small cell lung cancer gan Brown, Kathryn, Comisar, Craig, Witjes, Han, Maringwa, John, de Greef, Rik, Vishwanathan, Karthick, Cantarini, Mireille, Cox, Eugène

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Prognostic models for high and low ovarian responses in controlled ovarian stimulation using a GnRH antagonist protocol gan Broekmans, Frank J., Verweij, Pierre J.M., Eijkemans, Marinus J.C., Mannaerts, Bernadette M.J.L., Witjes, Han

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Maternal–Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing gan Lommerse, Jos, Clarke, Diana, Kerbusch, Thomas, Merdjan, Henri, Witjes, Han, Teppler, Hedy, Mirochnick, Mark, Acosta, Edward P., Wenning, Larissa, Nachman, Sharon, Chain, Anne

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Population Pharmacokinetic Modeling to Evaluate Standard Magnesium Sulfate Treatments and Alternative Dosing Regimens for Women With Preeclampsia gan Du, Lihong, Wenning, Larissa, Migoya, Elizabeth, Xu, Yan, Carvalho, Brendan, Brookfield, Kathleen, Witjes, Han, de Greef, Rik, Lumbiganon, Pisake, Sangkomkamhang, Ussanee, Titapant, Vitaya, Duley, Lelia, Long, Qian, Oladapo, Olufemi T.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Alternative Magnesium Sulfate Dosing Regimens for Women With Preeclampsia: A Population Pharmacokinetic Exposure‐Response Modeling and Simulation Study gan Du, Lihong, Wenning, Larissa A., Carvalho, Brendan, Duley, Lelia, Brookfield, Kathleen F., Witjes, Han, de Greef, Rik, Lumbiganon, Pisake, Titapant, Vitaya, Kongwattanakul, Kiattisak, Long, Qian, Sangkomkamhang, Ussanee S., Gülmezoglu, Ahmet M., Oladapo, Olufemi T.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

998. Forward and Reverse Translational Approaches to Predict Efficacy of the Neutralizing Respiratory Syncytial Virus (RSV) Antibody MK-1654 gan Maas, Brian M, Lommerse, Jos, Plock, Nele, Railkar, Radha, Amy Cheung, S Y, Caro, Luzelena, Chen, Jingxian, Liu, Wen, Zhang, Ying, Huang, Qinlei, Gao, Wei, Qin, Li, Meng, Jie, Witjes, Han, Schindler, Emilie, Guiastrennec, Benjamin, Bellanti, Francesco, Spellman, Daniel, Roadcap, Brad, Kalinova, Mariya, Fok-Seang, Juin, Catchpole, Andrew P, Espeseth, Amy, Aubrey Stoch, S, Lai, Eseng, Vora, Kalpit A, Aliprantis, Antonios O, Sachs, Jeffrey R

Cael y testun llawn Cael y testun llawn

Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxis gan Maas, Brian M., Lommerse, Jos, Plock, Nele, Railkar, Radha A., Cheung, S.Y. Amy, Caro, Luzelena, Chen, Jingxian, Liu, Wen, Zhang, Ying, Huang, Qinlei, Gao, Wei, Qin, Li, Meng, Jie, Witjes, Han, Schindler, Emilie, Guiastrennec, Benjamin, Bellanti, Francesco, Spellman, Daniel S., Roadcap, Brad, Kalinova, Mariya, Fok-Seang, Juin, Catchpole, Andrew P., Espeseth, Amy S., Stoch, S. Aubrey, Lai, Eseng, Vora, Kalpit A., Aliprantis, Antonios O., Sachs, Jeffrey R.

Cael y testun llawn Cael y testun llawn Cael y testun llawn